tradingkey.logo
tradingkey.logo
Search

24H|Mira Pharma Soars 47%; Minim Surges 42%; Datadog Jumps 11%; AppLovin and Robinhood Drop 1%

TigerJul 3, 2025 1:21 AM
facebooktwitterlinkedin
View all comments0

Shares of drug developer Mira Pharma soared 46.8% in overnight trading. The company said its experimental drug, Mira-55, a non-psychoactive marijuana analog showed morphine-comparable pain relief in a preclinical animal trial.

Shares of Minim rallied 42.3% after the software provider acquired a portfolio of intellectual property and fixed assets from Suzhou Yixuntong Network Technology for $1.4 million.

Software company Datadog will be added to the S&P 500 index next week, replacing Juniper Networks after its recent acquisition by Hewlett Packard Enterprise. Shares of Datadog were up 10.6% in overnight trading. The hope of AppLovin and Robinhood being selected has once again been dashed. Their shares both dropped more than 1%.

Reviewed byHuanyao Fang
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.